Evidence map›Paper›PMID 31914140›Full record

ArticlePloS one2020

Aqueous extract from Mangifera indica Linn. (Anacardiaceae) leaves exerts long-term hypoglycemic effect, increases insulin sensitivity and plasma insulin levels on diabetic Wistar rats.

Gustavo Roberto Villas Boas, João Marcos Rodrigues Lemos, Matheus William de Oliveira, Rafael Claudino Dos Santos, Ana Paula Stefanello da Silveira, Flávia Barbieri Bacha, Caren Naomi Aguero Ito, Ediane Bortolotte Cornelius, Fernanda Brioli Lima, Andrea Marisa Sachilarid Rodrigues and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Molecular Mechanisms and Antidiabetic Effects of Mango (International journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Potential use ofIndian journal of pharmacology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Gustavo Roberto Villas BoasResearch Group on Development of Pharmaceutical Products (P&DProFar), Center for Biological and Health Sciences, Federal University of Western Bahia, Barreiras, Bahia, Brazil.ORCID 0000-0003-1660-6480
João Marcos Rodrigues LemosFaculty of Health Sciences, University Center of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Matheus William de OliveiraFaculty of Health Sciences, University Center of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Rafael Claudino Dos SantosFaculty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Ana Paula Stefanello da SilveiraFaculty of Health Sciences, University Center of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Flávia Barbieri BachaFaculty of Health Sciences, University Center of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Caren Naomi Aguero ItoFaculty of Health Sciences, University Center of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Ediane Bortolotte CorneliusFaculty of Health Sciences, University Center of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Fernanda Brioli LimaFaculty of Health Sciences, University Center of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Andrea Marisa Sachilarid RodriguesFaculty of Health Sciences, University Center of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Nathália Belmal CostaFaculty of Health Sciences, University Center of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Felipe Francisco BittencourtFaculty of Health Sciences, University Center of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Fernando Freitas de LimaFaculty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Marina Meirelles PaesResearch Group on Development of Pharmaceutical Products (P&DProFar), Center for Biological and Health Sciences, Federal University of Western Bahia, Barreiras, Bahia, Brazil.
Priscila GubertResearch Group on Development of Pharmaceutical Products (P&DProFar), Center for Biological and Health Sciences, Federal University of Western Bahia, Barreiras, Bahia, Brazil.
Silvia Aparecida OesterreichFaculty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Universidade Federal da Grande Dourados · BRUniversidade Federal de Pernambuco · BRUniversidade Federal do Oeste da Bahia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes mellitus is one of the most common todays public health problems. According to a survey by the World Health Organization, this metabolic disorder has reached global epidemic proportions, with a worldwide prevalence of 8.5% in the adult population.

objectivesThe present study aimed to investigate the hypoglycemic effect of aqueous extract of Mangifera indica (EAMI) leaves in streptozotocin-induced diabetic rats.

methodsSixty male rats were divided into 2 groups: Normoglycemic and Diabetic. Each group was subdivided into negative control, glibenclamide 3 or 10 mg/kg, EAMI 125, 250, 500, and 1000 mg/kg. Intraperitoneal injection of streptozotocin 100 mg/kg was used to DM induction. The hypoglycemic response was assessed acutely after two and four weeks of treatment. After a 6-hour fasting period, the fasting blood glucose of animals was verified, and 2.5 g/kg glucose solution was orally administered. The insulin tolerance test and plasma insulin levels assessment were performed in the morning after fasting of 12 to 14 hours. RESULTS AND

conclusionThe chemical analysis of EAMI showed high levels of phenolic compounds. There was no significant difference in fasting blood glucose between normoglycemic and diabetic groups, and that EAMI did not have an acute effect on diabetes. After two and four weeks of treatment, the extract significantly reduced blood glucose levels, exceeding glibenclamide effects. EAMI was effective in maintaining the long-term hypoglycemic effect, as well as, significantly increased the sensitivity of diabetic animals to insulin and the plasma insulin level.

Indexed as

Insulin ResistanceAnimalsBlood GlucoseDiabetes Mellitus, ExperimentalHypoglycemic AgentsInsulinMaleMangiferaPlant ExtractsRats, WistarBlood GlucoseHypoglycemic AgentsInsulinMangifera indica extractPlant Extracts

Identifiers

PMID31914140
PMCPMC6948748
OpenAlexW3000579337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.